ScholarIQanswers from OpenAlex

Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies

PaperCitations, authors & open-access status

Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies have?

ScholarIQcitation count

Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies has 219 citations in the OpenAlex counts ScholarIQ stores.

When was Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies published?

ScholarIQyear

Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies has 2007 year in the ScholarIQ index.

Open the OpenAlex record →

What is the open-access status of Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies?

ScholarIQoa status

Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies has closed oa status in the ScholarIQ index.

Open the OpenAlex record →

What is the DOI of Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies?

ScholarIQdoi

The DOI for Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies is on the source record.

Open the DOI →

What is the PMID of Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies?

ScholarIQpmid

The PMID for Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies is on the source record.

Open the PMID →

What is the OpenAlex record for Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies?

ScholarIQopenalex

The OpenAlex for Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies is on the source record.

Open the OpenAlex →

Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies

How many citations does Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies have?

When was Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies published?

What is the open-access status of Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies?

What is the DOI of Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies?

What is the PMID of Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies?

What is the OpenAlex record for Inhibition of TGF- <i>β</i> 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies?

Related on ScholarIQ